Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMNE7L3)

Drug Name
CC-220 Drug Info
Synonyms AC1OEW2H; NPD6561; MCULE-9299015048; BCP9000573; BCP0726000266
Indication
Disease Entry ICD 11 Status REF
Sarcoidosis 4B20.5 Phase 2 [1]
Systemic lupus erythematosus 4A40.0 Phase 2 [2]
Multiple myeloma 2A83 Phase 1 [3]
Cross-matching ID
PubChem CID
67335295
CAS Number
CAS 1323403-33-3
TTD Drug ID
DMNE7L3

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Protein cereblon (CRBN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CC-122 DM0SRAN Chronic lymphocytic leukaemia 2A82.0 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein cereblon (CRBN) TTDKGTC CRBN_HUMAN Inhibitor [3]

References

1 ClinicalTrials.gov (NCT02185040) A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)